Skip to main content
Year archive

Cantargia — 2020 filings

All 74 regulatory filings released by Cantargia (CANTA) in 2020, sourced directly from the official regulator.

74 Filings
2020 Period
2020 filings (74)
Filing Released Lang
Nytt antal aktier och röster i Cantargia
Declaration of Voting Results & Voting Rights Announcements
2020-12-30 Swedish
New number of shares and votes in Cantargia
Share Issue/Capital Change
2020-12-30 English
Ändring i Cantargias valberedning
Board/Management Information
2020-12-21 Swedish
Changes to Cantargia’s nomination committee
Board/Management Information
2020-12-21 English
Cantargia has completed a directed share issue of approximately SEK 564 million
Share Issue/Capital Change
2020-12-16 English
Cantargia har genomfört en riktad nyemission av aktier om cirka SEK 564 miljoner
Share Issue/Capital Change
2020-12-16 Swedish
Cantargia announces intention of a directed share issue
Share Issue/Capital Change
2020-12-15 English
Cantargia offentliggör avsikt att genomföra riktad nyemission av aktier
Share Issue/Capital Change
2020-12-15 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-12 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-12 English
Valberedning utsedd inför årsstämman 2021
Board/Management Information
2020-10-20 Swedish
Nomination Committee appointed ahead of 2021 Annual General Meeting
Regulatory Filings
2020-10-20 English
Extraordinary general meeting in Cantargia AB (publ)
AGM Information
2020-10-13 English
Extra bolagsstämma i Cantargia AB (publ)
AGM Information
2020-10-13 Swedish
Cantargia slutför rekryteringen och rapporterar en positiv interims-uppdatering av kombinationsstudien med CAN04 i bukspottkörtelcancer
Earnings Release FY 2020
2020-10-08 Swedish
Cantargia completes recruitment and reports positive interim update in CAN04 pancreatic cancer combination therapy
Regulatory Filings
2020-10-08 English
Cantargia reports first patient treated with CAN04 in a US phase I study investigating combination with pembrolizumab
Regulatory Filings
2020-10-02 English
Cantargia rapporterar att första patienten behandlats med CAN04 i en fas I studie i USA som studerar kombination med pembrolizumab
Regulatory Filings
2020-10-02 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-10-01 English
Sunstone säljer 1 500 000 Cantargia-aktier till en av Cantargias större institutionella investerare
Major Shareholding Notification
2020-10-01 Swedish
Cantargia reports high response rates with CAN04 combination therapy in NSCLC and presents next development steps
Legal Proceedings Report
2020-09-23 English
Cantargia rapporterar höga responsnivåer med CAN04 kombinationsterapi i NSCLC och presenterar kommande utvecklingssteg
Regulatory Filings
2020-09-23 Swedish
Notice of extraordinary general meeting in Cantargia AB (publ)
AGM Information
2020-09-21 English
Kallelse till extra bolagsstämma i Cantargia AB (publ)
AGM Information
2020-09-21 Swedish
Cantargia’s nomination committee proposes a new board member
Board/Management Information
2020-09-21 English
Cantargias valberedning föreslår ny styrelseledamot
Board/Management Information
2020-09-21 Swedish
Annual Report 2019
Annual Report FY 2019
2020-08-24 English
Annual Report 2018
Annual Report FY 2018
2020-08-24 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H2 2020
2020-08-20 English
New number of shares and votes in Cantargia
Declaration of Voting Results & Voting Rights Announcements
2020-07-31 English
Nytt antal aktier och röster i Cantargia
Share Issue/Capital Change
2020-07-31 Swedish
Cantargia förstärker sin ledningsgrupp med VP Regulatory Affairs och VP CMC
Board/Management Information
2020-06-23 Swedish
Cantargia strengthens management team with VP Regulatory Affairs and VP CMC
Board/Management Information
2020-06-23 English
Cantargia presents new preclinical data on CAN04 at the 2020 AACR Annual Meeting
Regulatory Filings
2020-06-22 English
Cantargia presenterar nya prekliniska resultat kring CAN04 på 2020 AACR Annual Meeting
Regulatory Filings
2020-06-22 Swedish
Årsstämma i Cantargia AB (publ)
AGM Information
2020-05-27 Swedish
Annual General Meeting in Cantargia AB (publ)
AGM Information
2020-05-27 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-27 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-27 English
Cantargia presents new preclinical data on CAN04 in combination with chemotherapy at the 2020 AACR Annual Meeting
Regulatory Filings
2020-05-15 English
Cantargia presenterar nya prekliniska data på CAN04 i kombination med cellgifter på 2020 AACR Annual Meeting
Regulatory Filings
2020-05-15 Swedish
Cantargia IND application for CAN04 approved by FDA
Legal Proceedings Report
2020-05-04 English
Cantargias ansökan om IND för CAN04 godkänd av FDA
Legal Proceedings Report
2020-05-04 Swedish
Annual Report 2019
Annual Report FY 2019
2020-04-30 Swedish
Kallelse till årsstämma i Cantargia AB (publ)
AGM Information
2020-04-28 Swedish
Notice of annual general meeting in Cantargia AB (publ)
AGM Information
2020-04-28 English
Cantargia submits IND application for CAN04
Legal Proceedings Report
2020-04-07 English
Cantargia ansöker om IND för CAN04
Regulatory Filings
2020-04-07 Swedish
Rättelse: Justering av MAR-klassificering i tidigare pressmeddelande ”Cantargia ger uppdatering om utvecklingsprojekten CAN04 och CAN10”
Regulatory Filings
2020-04-07 Swedish
Cantargia provides update on development projects CAN04 and CAN10
Regulatory Filings
2020-04-07 English
Cantargia ger uppdatering om utvecklingsprojekten CAN04 och CAN10
Regulatory Filings
2020-04-07 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-04-01 Swedish
New number of shares and votes in Cantargia
Declaration of Voting Results & Voting Rights Announcements
2020-03-31 English
Nytt antal aktier och röster i Cantargia
Share Issue/Capital Change
2020-03-31 Swedish
Prospekt avseende upptagande till handel av aktier i Cantargia offentliggjort
Capital/Financing Update
2020-03-20 Swedish
Prospectus relating to the listing of shares in Cantargia published
Report Publication Announcement
2020-03-20 English
Extra bolagsstämma i Cantargia AB (publ)
AGM Information
2020-03-16 Swedish
Extraordinary general meeting in Cantargia AB (publ)
AGM Information
2020-03-16 English
Nytt antal aktier och röster i Cantargia
Share Issue/Capital Change
2020-02-28 Swedish
New number of shares and votes in Cantargia
Share Issue/Capital Change
2020-02-28 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q4 2019
2020-02-27 Swedish
Audit Report / Information 2019
Audit Report / Information FY 2019
2020-02-27 English
Cantargia appoints Dr. Ignacio Garcia-Ribas as Chief Medical Officer
Board/Management Information
2020-02-25 English
Cantargia anställer Dr. Ignacio Garcia-Ribas som Chief Medical Officer
Board/Management Information
2020-02-25 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-21 English
Notice of extraordinary general meeting in Cantargia AB (publ)
AGM Information
2020-02-21 English
Kallelse till extra bolagsstämma i Cantargia AB (publ)
AGM Information
2020-02-21 Swedish
Cantargia has completed a directed share issue of approximately SEK 410 million
Capital/Financing Update
2020-02-19 English
Cantargia har genomfört en riktad nyemission av aktier om cirka SEK 410 miljoner
Share Issue/Capital Change
2020-02-19 Swedish
Cantargia announces intention of a directed share issue
Capital/Financing Update
2020-02-19 English
Cantargia offentliggör avsikt att genomföra riktad nyemission av aktier
Share Issue/Capital Change
2020-02-19 Swedish
Cantargia avancerar utvecklingen av CAN04 genom framgångsrik uppskalning av produktionen
Regulatory Filings
2020-02-14 Swedish
Cantargia advances development of CAN04 through successful production scale up
Regulatory Filings
2020-02-14 English